BioInnovatise is a growing, minority-owned biotechnology company that serves research and development laboratories in the I-270 Technology Corridor, BioCapital, and beyond. The company operates as a Contract Manufacturing Organisation (CMO) and Contract Development and Manufacturing Organisation (CDMO), offering a diverse range of services tailored to meet the demands of numerous startups, large pharmaceutical companies, academic labs, and government agencies, including the NIH and FDA. BioInnovatise specialises in molecular biology products and services aimed at advancing research in the early discovery phases of cell and gene therapy, immunotherapy, precision medicine, regenerative medicine, stem cell research, and vaccine development. Researchers rely on their commitment to high-quality production with minimal turnaround time, making BioInnovatise a trusted partner in the pursuit of groundbreaking discoveries across various scientific fields.

Services include:
- Biologics
- Cell and Gene Therapy
- Research & Development
- Bioprocessing
- Contract Manufacturing (CMO)
- Manufacturing
- Contract Development
- Gene Therapy & Testing Protocols
- Immunobiology Services
- Quality QA/QC
- Stem Cells

BioInnovatise continues to support researchers in their innovative pursuits, driving advancements in biotechnology. For more information, please visit bioinnovatise.com.